[1] Sepehri ZS, Masoomi M, Ruzbehi F, Kiani Z, Nasiri AA, Kohan F, et al. Comparison of serum levels of IL-6, IL-8, TGF-beta and TNF-alpha in coronary artery diseases, stable angina and participants with normal coronary artery. Cell Mol Biol (Noisy-le-grand) 2018 Apr 30;64(5):1-6.
[2] Kwasny C, Manuwald U, Kugler J, Rothe U. Systematic Review of the Epidemiology and Natural History of the Metabolic Vascular Syndrome and its Coincidence with Type 2 Diabetes Mellitus and Cardiovascular Diseases in Different European Countries. Horm Metab Res 2018 Mar;50(3):201-8.
[3] Devabhaktuni S, Mercedes A, Diep J, Ahsan C. Coronary Artery Ectasia-A Review of Current Literature. Curr Cardiol Rev 2016;12(4):318-23.
[4] Akbari H, Asadikaram G, Vakili S, Masoumi M. Atorvastatin and losartan may upregulate renalase activity in hypertension but not coronary artery diseases: The role of gene polymorphism. J Cell Biochem 2019 Jun;120(6):9159-71.
[5] Asadikaram G, Ram M, Izadi A, Sheikh Fathollahi M, Nematollahi MH, Najafipour H, et al. The study of the serum level of IL-4, TGF-beta, IFN-gamma, and IL-6 in overweight patients with and without diabetes mellitus and hypertension. J Cell Biochem 2019 Mar;120(3):4147-57.
[6] Qin Y, Tang C, Ma C, Yan G. Risk factors for coronary artery ectasia and the relationship between hyperlipidemia and coronary artery ectasia. Coron Artery Dis 2019 May;30(3):211-5.
[7] Doi T, Kataoka Y, Noguchi T, Shibata T, Nakashima T, Kawakami S, et al. Coronary Artery Ectasia Predicts Future Cardiac Events in Patients With Acute Myocardial Infarction. Arterioscler Thromb Vasc Biol 2017 Dec;37(12):2350-5.
[8] Antonopoulos AS, Siasos G, Oikonomou E, Mourouzis K, Mavroudeas SE, Papageorgiou N, et al. Characterization of vascular phenotype in patients with coronary artery ectasia: The role of endothelial dysfunction. Int J Cardiol 2016 Jul 15;215:138-9.
[9] Ovali C, Morrad B. Associations between coronary artery disease, aneurysm and ectasia. Kardiochir Torakochirurgia Pol 2017 Sep;14(3):158-63.
[10] Dahhan A. Coronary artery ectasia in atherosclerotic coronary artery disease, inflammatory disorders, and sickle cell disease. Cardiovasc Ther 2015 Apr;33(2):79-88.
[11] Masoomi M, Ramezani MA, Karimzadeh H. The relationship of opium addiction with coronary artery disease. Int J Prev Med 2010 Summer;1(3):182-6.
[12] Ebdali RT, Tabaee SS, Tabaei S. Cardiovascular complications and related risk factors underlying opium consumption. J Cell Physiol 2019 Jun;234(6):8487-95.
[13] Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J 2015 Jan 10;14:6.
[14] Ahmed R, Khandelwal G, Bansal A, Jain A, Khandelwal K, Singla R. Prevalence and clinical profile of angiographic coronary artery ectasia among North Indian population. Journal of Natural Science, Biology and Medicine 2019;10(1):72.
[15] Hussain SS, Farhat S, Rather YH, Abbas Z. Comparative trial to study the effectiveness of clonidine hydrochloride and buprenorphine-naloxone in opioid withdrawal - a hospital based study. J Clin Diagn Res 2015 Jan;9(1):FC01-4.
[16] Esmaeili Nadimi A, Pour Amiri F, Sheikh Fathollahi M, Hassanshahi G, Ahmadi Z, Sayadi AR. Opium addiction as an independent risk factor for coronary microvascular dysfunction: A case-control study of 250 consecutive patients with slow-flow angina. Int J Cardiol 2016 Sep 15;219:301-7.
[17] Naruszewicz M. [Homocysteine as a residual risk factor in cardiovascular diseases]. Kardiol Pol 2010 Mar;68(3):283-4.
[18] Ebesunun MO, Obajobi EO. Elevated plasma homocysteine in type 2 diabetes mellitus: a risk factor for cardiovascular diseases. Pan Afr Med J 2012;12:48.
[19] Forood A, Malekpour-Afshar R, Mahdavi A. Serum level of plasminogen activator inhibitor type-1 in addicted patients with coronary artery disease. Addict Health 2014 Summer-Autumn;6(3-4):119-26.
[20] Azdaki N, Zardast M, Anani-Sarab G, Abdorrazaghnaejad H, Ghasemian MR, Saburi A. Comparison between Homocysteine, Fibrinogen, PT, PTT, INR and CRP in Male Smokers with/without Addiction to Opium. Addict Health 2017 Jan;9(1):17-23.
[21] Masoomi M, Azdaki N, Shahouzehi B. Elevated Plasma Homocysteine Concentration in Opium-Addicted Individuals. Addict Health 2015 Summer-Autumn;7(3-4):149-56.
[22] Gholamhossenian A, Shahouzehi B, Shokoohi M, Najafipour H. B12 and Folate Concentrations in Opium Addicts Compared to Healthy Subjects: A Case Control Study from Kerman Coronary Artery Disease Risk Study. Addict Health 2018 Jul;10(3):198-204.